# Jeff Dunkel

> Jeff Dunkel is the CEO of Optain, with previous leadership roles at Titan Spine, NuHope, and Mindset Medical and experience at Johnson & Johnson. Originally from Memphis and based in Matthews, North Carolina, he has worked across commercial strategy, contracting, public-sector collaboration, and company growth. Optain launched in 2023 and announced a $26 million Series A and the acquisition of EyePACS in 2025.

- **Role:** Co-founder and Chief Executive Officer at Optain
- **Organizations:** Optain, Titan Spine, NuHope, Mindset Medical, Johnson & Johnson, MDEpiNet
- **Education:** Bachelor of Science, Indiana University, Indiana University - Kelley School of Business
- **Known for:** Held strategy and executive roles across startups and established companies., Led Optain during its $26 million Series A and acquisition of EyePACS in 2025., Appointed to the MDEpiNet Executive Operations Committee.

## Career timeline

- **2014** — Joined Titan Spine.
- **2016** — Titan Spine announced his appointment to the MDEpiNet Executive Operations Committee; his title was Vice President, Strategic Partnering.
- **2019** — Spoke at a federal public hearing while at Titan Spine and described pro bono work with more than ten small innovative companies.
- **2020** — Appointed CEO of NuHope on January 28 after serving as Titan Spine EVP of Strategy.
- **2023** — Became Optain CEO; the company publicly launched on May 9 with a $12 million initial seed investment.
- **2025** — Optain announced a $26 million Series A on September 10 and its acquisition of EyePACS on November 6.

## Achievements

- Held strategy and executive roles across startups and established companies.
- Led Optain during its $26 million Series A and acquisition of EyePACS in 2025.
- Appointed to the MDEpiNet Executive Operations Committee.

## Latest updates

- **2026-03** — Featured in an Insight Partners leadership profile published March 9.
- **2025-12** — Appeared with Zachary Tan on the Tech It to the Limit episode published December 19.
- **2025-11** — Optain announced its acquisition of EyePACS following two years of collaboration.
- **2025-09** — Optain announced a $26 million Series A led by Insight Partners.

## Links

- LinkedIn: https://www.linkedin.com/in/jeff-dunkel-5529aa4

---

Profile page: https://yespress.io/jeff-dunkel
Published by YesPress — https://yespress.io
Last updated: 2026-10-25